US 11524017
Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs
granted A61KA61K31/11A61K31/121
Quick answer
US patent 11524017 (Method of using substrates of AKR1B1/AKR1B10 as anti-cancer drugs) held by Beijing Normal University Hong Kong Baptist University United International College expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Beijing Normal University Hong Kong Baptist University United International College
- Grant date
- Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/11, A61K31/121, A61K31/19, A61K31/191